Molecular Endocrinology, Vol 7, 1399-1407, Copyright © 1993 by Endocrine Society

ARTICLES

Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation

JJ Palvimo, PJ Kallio, T Ikonen, M Mehto and OA Janne
Department of Physiology, University of Helsinki, Finland.

A series of deletion mutants was constructed for the rat androgen receptor (AR) to delineate sequences involved in transcriptional activation. Using transient expression conditions in CV-1 cells and in vitro DNA-binding studies, the amino-terminal domain of the receptor was shown to contain a region (residues 147-296) that is mandatory for trans-activation. Receptors with deletions (residues 147-408) in the N- terminal domain, but with intact DNA- and ligand-binding domains, interacted in vitro with androgen-responsive elements albeit with affinities lower than that of the wild type receptor. Coexpression of N- terminal deletion mutants (delta 46-408 and delta 38-296) with the wild type AR blunted trans-activation by the latter protein in a dominant fashion. By contrast, a hormone-binding-deficient receptor (delta 788- 902) that had poor intrinsic activity potentiated the trans-activation by the native receptor. Mechanisms by which deletion mutants in the N- terminal region abolish the function of the wild type protein appear to involve heterodimer formation during interaction with DNA and direct competition for available binding sites on DNA, rather than squelching of accessory proteins. In contrast to impaired trans-activation, binding of the ligand to N-terminal deletion mutants brought about conformational changes that were comparable in wild type and mutant forms, as judged by electrophoretic mobility shift assays. Taken together, these data have specified a region in the N-terminal domain of the AR that plays a decisive role in transcriptional regulation.

This article has been cited by other articles:

				W. Zhao, J. Pan, X. Wang, Y. Wu, W. A. Bauman, and C. P. Cardozo Expression of the Muscle Atrophy Factor Muscle Atrophy F-Box Is Suppressed by Testosterone Endocrinology, November 1, 2008; 149(11): 5449 - 5460. [Abstract] [Full Text] [PDF]

				Y. Wu, W. Zhao, J. Zhao, J. Pan, Q. Wu, Y. Zhang, W. A. Bauman, and C. P. Cardozo Identification of Androgen Response Elements in the Insulin-Like Growth Factor I Upstream Promoter Endocrinology, June 1, 2007; 148(6): 2984 - 2993. [Abstract] [Full Text] [PDF]

				L. M. Butler, M. M. Centenera, P. J. Neufing, G. Buchanan, C. S. Y. Choong, C. Ricciardelli, K. Saint, M. Lee, A. Ochnik, M. Yang, et al. Suppression of Androgen Receptor Signaling in Prostate Cancer Cells by an Inhibitory Receptor Variant Mol. Endocrinol., May 1, 2006; 20(5): 1009 - 1024. [Abstract] [Full Text] [PDF]

				L. Callewaert, N. Van Tilborgh, and F. Claessens Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor Cancer Res., January 1, 2006; 66(1): 543 - 553. [Abstract] [Full Text] [PDF]

				G. Penot, C. Le Peron, Y. Merot, E. Grimaud-Fanouillere, F. Ferriere, N. Boujrad, O. Kah, C. Saligaut, B. Ducouret, R. Metivier, et al. The Human Estrogen Receptor-{alpha} Isoform hER{alpha}46 Antagonizes the Proliferative Influence of hER{alpha}66 in MCF7 Breast Cancer Cells Endocrinology, December 1, 2005; 146(12): 5474 - 5484. [Abstract] [Full Text] [PDF]

				K. A. Link, C. J. Burd, E. Williams, T. Marshall, G. Rosson, E. Henry, B. Weissman, and K. E. Knudsen BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF Mol. Cell. Biol., March 15, 2005; 25(6): 2200 - 2215. [Abstract] [Full Text] [PDF]

				H. I Scher, G. Buchanan, W. Gerald, L. M Butler, and W. D Tilley Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer Endocr. Relat. Cancer, September 1, 2004; 11(3): 459 - 476. [Abstract] [Full Text] [PDF]

				M. Tujague, J. S. Thomsen, K. Mizuki, C. M. Sadek, and J.-A. Gustafsson The Focal Adhesion Protein Vinexin {alpha} Regulates the Phosphorylation and Activity of Estrogen Receptor {alpha} J. Biol. Chem., March 5, 2004; 279(10): 9255 - 9263. [Abstract] [Full Text] [PDF]

				P. Sipila, R. Shariatmadari, I. T. Huhtaniemi, and M. Poutanen Immortalization of Epididymal Epithelium in Transgenic Mice Expressing Simian Virus 40 T Antigen: Characterization of Cell Lines and Regulation of the Polyoma Enhancer Activator 3 Endocrinology, January 1, 2004; 145(1): 437 - 446. [Abstract] [Full Text] [PDF]

				C. E. Petre-Draviam, S. L. Cook, C. J. Burd, T. W. Marshall, Y. B. Wetherill, and K. E. Knudsen Specificity of Cyclin D1 for Androgen Receptor Regulation Cancer Res., August 15, 2003; 63(16): 4903 - 4913. [Abstract] [Full Text] [PDF]

				N. Kotaja, U. Karvonen, O. A. Janne, and J. J. Palvimo PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases Mol. Cell. Biol., July 15, 2002; 22(14): 5222 - 5234. [Abstract] [Full Text] [PDF]

				N. Kotaja, M. Vihinen, J. J. Palvimo, and O. A. Janne Androgen Receptor-interacting Protein 3 and Other PIAS Proteins Cooperate with Glucocorticoid Receptor-interacting Protein 1 in Steroid Receptor-dependent Signaling J. Biol. Chem., May 10, 2002; 277(20): 17781 - 17788. [Abstract] [Full Text] [PDF]

				T. Ueda, N. Bruchovsky, and M. D. Sadar Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways J. Biol. Chem., February 22, 2002; 277(9): 7076 - 7085. [Abstract] [Full Text] [PDF]

				J. Thompson, F. Saatcioglu, O. A. Janne, and J. J. Palvimo Disrupted Amino- and Carboxyl-Terminal Interactions of the Androgen Receptor Are Linked to Androgen Insensitivity Mol. Endocrinol., June 1, 2001; 15(6): 923 - 935. [Abstract] [Full Text] [PDF]

				N. Kotaja, S. Aittomäki, O. Silvennoinen, J. J. Palvimo, and O. A. Jänne ARIP3 (Androgen Receptor-Interacting Protein 3) and Other PIAS (Protein Inhibitor of Activated STAT) Proteins Differ in Their Ability to Modulate Steroid Receptor-Dependent Transcriptional Activation Mol. Endocrinol., December 1, 2000; 14(12): 1986 - 2000. [Abstract] [Full Text]

				T. Slagsvold, I. Kraus, T. Bentzen, J. Palvimo, and F. Saatcioglu Mutational Analysis of the Androgen Receptor AF-2 (Activation Function 2) Core Domain Reveals Functional and Mechanistic Differences of Conserved Residues Compared with Other Nuclear Receptors Mol. Endocrinol., October 1, 2000; 14(10): 1603 - 1617. [Abstract] [Full Text]

				H. Poukka, P. Aarnisalo, H. Santti, O. A. Janne, and J. J. Palvimo Coregulator Small Nuclear RING Finger Protein (SNURF) Enhances Sp1- and Steroid Receptor-mediated Transcription by Different Mechanisms J. Biol. Chem., January 7, 2000; 275(1): 571 - 579. [Abstract] [Full Text] [PDF]

				H. Poukka, P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription J. Biol. Chem., July 2, 1999; 274(27): 19441 - 19446. [Abstract] [Full Text] [PDF]

				P. Aarnisalo, H. Santti, H. Poukka, J. J. Palvimo, and O. A. Jänne Transcription Activating and Repressing Functions of the Androgen Receptor Are Differentially Influenced by Mutations in the Deoxyribonucleic Acid-Binding Domain Endocrinology, July 1, 1999; 140(7): 3097 - 3105. [Abstract] [Full Text]

				M. D. Sadar Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways J. Biol. Chem., March 19, 1999; 274(12): 7777 - 7783. [Abstract] [Full Text] [PDF]

				A.-M. Moilanen, U. Karvonen, H. Poukka, W. Yan, J. Toppari, O. A. Janne, and J. J. Palvimo A Testis-specific Androgen Receptor Coregulator That Belongs to a Novel Family of Nuclear Proteins J. Biol. Chem., February 5, 1999; 274(6): 3700 - 3704. [Abstract] [Full Text] [PDF]

				A. Scheller, E. Hughes, K. L. Golden, and D. M. Robins Multiple Receptor Domains Interact to Permit, or Restrict, Androgen-specific Gene Activation J. Biol. Chem., September 11, 1998; 273(37): 24216 - 24222. [Abstract] [Full Text] [PDF]

				A.-M. Moilanen, H. Poukka, U. Karvonen, M. Häkli, O. A. Jänne, and J. J. Palvimo Identification of a Novel RING Finger Protein as a Coregulator in Steroid Receptor-Mediated Gene Transcription Mol. Cell. Biol., September 1, 1998; 18(9): 5128 - 5139. [Abstract] [Full Text]

				A.-M. Moilanen, U. Karvonen, H. Poukka, O. A. Jänne, and J. J. Palvimo Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase Mol. Biol. Cell, September 1, 1998; 9(9): 2527 - 2543. [Abstract] [Full Text]

				P. Aarnisalo, J. J. Palvimo, and O. A. Janne CREB-binding protein in androgen receptor-mediated signaling PNAS, March 3, 1998; 95(5): 2122 - 2127. [Abstract] [Full Text] [PDF]

				T. Ikonen, J. J. Palvimo, and O. A. Janne Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators J. Biol. Chem., November 21, 1997; 272(47): 29821 - 29828. [Abstract] [Full Text] [PDF]

				L. L. Heckert, E. M. Wilson, and J. H. Nilson Transcriptional Repression of the {alpha}-Subunit Gene by Androgen Receptor Occurs Independently of DNA Binding but Requires the DNA-Binding and Ligand-Binding Domains of the Receptor Mol. Endocrinol., September 1, 1997; 11(10): 1497 - 1506. [Abstract] [Full Text]

				I. J. McEwan and J.-A. Gustafsson Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF PNAS, August 5, 1997; 94(16): 8485 - 8490. [Abstract] [Full Text] [PDF]

				U. Karvonen, P. J. Kallio, O. A. Janne, and J. J. Palvimo Interaction of Androgen Receptors with Androgen Response Element in Intact Cells. ROLES OF AMINO- AND CARBOXYL-TERMINAL REGIONS AND THE LIGAND J. Biol. Chem., June 20, 1997; 272(25): 15973 - 15979. [Abstract] [Full Text] [PDF]

				P. M. Yen, Y. Liu, J. J. Palvimo, M. Trifiro, J. Whang, L. Pinsky, O. A. Jänne, and W. W. Chin Mutant and Wild-Type Androgen Receptors Exhibit Cross-Talk on Androgen-, Glucocorticoid-, and Progesterone-Mediated Transcription Mol. Endocrinol., February 1, 1997; 11(2): 162 - 171. [Abstract] [Full Text]

				N. L. Chamberlain, D. C. Whitacre, and R. L. Miesfeld Delineation of Two Distinct Type 1Activation Functions in the Androgen Receptor Amino-terminal Domain J. Biol. Chem., October 25, 1996; 271(43): 26772 - 26778. [Abstract] [Full Text] [PDF]

				J. J. Palvimo, P. Reinikainen, T. Ikonen, P. J. Kallio, A. Moilanen, and O. A. Janne Mutual Transcriptional Interference between RelA and Androgen Receptor J. Biol. Chem., September 27, 1996; 271(39): 24151 - 24156. [Abstract] [Full Text] [PDF]

				E. Langley, Z.-x. Zhou, and E. M. Wilson Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer J. Biol. Chem., December 15, 1995; 270(50): 29983 - 29990. [Abstract] [Full Text] [PDF]